Dysfunctional platelet membrane receptors: From humans to mice

Thrombosis and Haemostasis

Volumn 92, Issue 3, 2004, Pages 478-485

  Ware, Jerry ^a,b  

^a Roon Res Ctr Arteriosclerosis T   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Animal; Animals; Bleeding time; Comparative study; Disease models; Mice; Mice knockout; Mice mutant strains; Platelets; Tail blood supply

Indexed keywords

COLLAGEN RECEPTOR; FIBRINOGEN RECEPTOR; MEMBRANE RECEPTOR; PROTEINASE ACTIVATED RECEPTOR; PURINE P2Y1 RECEPTOR; PURINE P2Y12 RECEPTOR; THROMBOCYTE RECEPTOR; GLYCOPROTEIN IB; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4; PURINE P2Y RECEPTOR; PURINE RECEPTOR; VERY LATE ACTIVATION ANTIGEN 2;

ANIMAL MODEL; ARTICLE; BLEEDING; EX VIVO STUDY; GENE TARGETING; GENOME; HEMOSTASIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MOLECULAR INTERACTION; MOUSE; MOUSE STRAIN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; THROMBOCYTE; THROMBOSIS; VASCULARIZATION; DISEASE MODEL; REVIEW;

ANIMALS; HEMOSTASIS; HUMANS; MICE; PLATELET ACTIVATION; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, CELL SURFACE; THROMBOSIS;

EID: 4544321716     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-05-0308     Document Type: Article

References (67)

1. Tsakiris DA, Scudder L, Hodivala-Dilke K, et al. Hemostasis in the mouse (Mus musculus): a review. Thromb Haemost 1999; 81: 177-88.
2. Jackson CW, Steward SA, Chenaille PJ, et al. An analysis of megakaryocytopoiesis in the C3H mouse: an animal model whose megakaryocytes have 32N as the modal DNA class. Blood 1990; 76: 690-6.
3. Levin J, Ebbe S. Why are recently published platelet counts in normal mice so low? Blood 1994; 83: 3829-31.
4. Corash L. The relationship between megakaryocyte ploidy and platelet volume. Blood Cells 1989; 15: 81-107.
5. Ault KA, Knowles C. In vivo biotinylation demonstrates that reticulated platelets are the youngest platelets in circulation. Exp Hematol 1995; 23: 996-1001.
6. Schmitt A, Guichard J, Masse JM, et al. Of mice and men: comparison of the ultrastructure of megakaryocytes and platelets. Exp Hematol 2001; 29: 1295-302.
7. Rosenblum WI, Nelson GH, Cockrell CS, et al. Some properties of mouse platelets. Thromb Res 1983; 30: 347-55.
8. Foster CJ, Prosser DM, Agans JM, et al. Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J Clin Invest 2001; 107 (12): 1591-8.
9. Leng XH, Hong SY, Larrucea S, et al. Platelets of female mice are intrinsically more sensitive to agonists than are platelets of males. Arterioscler Thromb Vasc Biol 2004; 24: 376-81.
10. Torres Duarte AP, Ramwell P, Myers A. Sex differences in mouse platelet aggregation. Thromb Res 1986; 43: 33-9.
11. Berndt MC, Shen Y, Dopheide SM, et al. The vascular biology of the glycoprotein Ib-IX-V complex. Thromb Haemost 2001; 86: 178-88.
12. Lopez JA, Weisman S, Sanan DA, Sih T, Chambers M, Li CQ. Glycoprotein (GP) Ibβ is the critical subunit linking GP Ibα and GP IX in the GP Ib-IX complex. J Biol Chem 1994; 269: 23716-21.
13. Lanza F, Morales M, La Salle C, T et al. Cloning and characterization of the gene encoding the human platelet glycoprotein V. J Biol Chem 1993; 268: 20801-7.
14. Lopez JA, Andrews RK, Afshar-Kharghan V, et al. Bernard-Soulier syndrome. Blood 1998; 91: 4397-18.
15. Ware J, Russell S, Ruggeri ZM. Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome. Proc Natl Acad Sci USA 2000; 97: 2803-8.
16. Poujol C, Ware J, Nieswandt B, et al. Absence of GP Ibα is responsible for the aberrant membrane development during megakaryocyte differentiation: an ultrastructural study. Exp Hematol 2002; 30: 352-60.
17. Kanaji T, Russell S, Ware J. Amelioration of the macrothrombocytopenia associated with the murine Bernard-Soulier syndrome. Blood 2002; 100: 2102-7.
18. Ramakrishnan V, Reeves PS, DeGuzman F, et al. Increased thrombin responsiveness in platelets from mice lacking glycoprotein V. Proc Natl Acad Sci USA 1999; 96: 13336-41.
19. Kahn ML, Diacovo TG, Bainton DF, et al. Glycoprotein V-deficient platelets do not exhibit a Bernard-Soulier phenotype and retain normal thrombin responsiveness. Blood 1999; 94: 4112-21.
20. Celikel R, McClintock RA, Roberts JR, et al. Modulation of α-thrombin function of distinct interactions with platelet glycoprotein Ibα. Science 2003; 301: 218-21.
21. Dumas JJ, Kumar R, Seehra J, et al. Crystal structure of the GpIbα-thrombin complex essential for platelet aggregation. Science 2003; 301: 222-6.
22. Seligsohn U. Glanzmann thrombasthenia: a model disease which paved the way to powerful therapeutic agents. Pathophysiol Haemost Thromb 2002; 32: 216-7.
23. Nair S, Ghosh K, Kulkarni B, et al. Glanzmann's thrombasthenia: updated. Platelets 2002; 13 (7): 387-93.
24. Hood JD, Cheresh DA. Role of integrins in cell invasion and migration. Nat Rev Cancer 2002; 2: 91-100.
25. Hodivala-Dilke KM, McHugh KP, Tsakiris DA, et al. Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest 1999; 103: 229-38.
26. Clemetson KJ, Clemetson JM. Platelet collagen receptors. Thromb Haemost 2001; 86: 189-98.
27. Clemetson JM, Polgar J, Magnenat E, et al. The platelet collagen receptor glycoprotein VI Is a member of the immunoglobulin superfamily closely related to FcγR and the natural killer receptors. J Biol Chem 1999; 274: 29019-24.
28. Chiang TM, Rinaldy A, Kang AH. Cloning, characterization, and functional studies of a nonintegrin platelet receptor for type I collagen. J Clin Invest 1997; 100: 514-29.
29. Nieswandt B, Brakebusch C, Bergmeier W, et al. Glycoprotein VI but not α2β1 integrin is essential for platelet interaction with collagen. EMBO J 2001; 20: 2120-30.
30. 2 integrin subunit-deficient mouse: a multifaceted phenotype including defects in branching morphogenesis and hemostasis. Am J Pathol 2002; 161: 337-44.
31. Kato K, Kanaji T, Russell S, et al. The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion. Blood 2003; 102: 1701-7.
32. Takai T, Li M, Sylvestre D, et al. FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell 1994; 76: 519-29.
33. Massberg S, Gawaz M, Grüner S, et al. A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med 2003; 197: 41-9.
34. Nieswandt B, Watson SP. Platelet-collagen interaction: is GPVI the central receptor? Blood 2003; 102(2): 449-61.
35. Dörmann D, Clemetson JM, Navdaev A, et al. Alboaggregin A activates platelets by a mechanism involving glycoprotein VI as well as glycoprotein Ib. Blood 2001; 97: 929-36.
36. Kanaji S, Kanaji T, Furihata K, et al. Convulxin binds to native, human glycoprotein Ibα (GPIbα). J Biol Chem 2003; 278: 39452-60.
37. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature 2000; 407(6801): 258-64.
38. Coughlin SR. Protease-activated receptors in the cardiovascular system. Cold Spring Harb Symp Quant Biol 2002; 67: 197-208.
39. Vu T-KH, Hung DT, Wheaton VI, et al. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-68.
40. Kahn ML, Nakanishi-Matsui M, Shapiro MJ, et al. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest 1999; 103: 879-87.
41. Kahn MJ, Zheng YW, Huang W, et al. A dual thrombin receptor system for platelet activation. Nature 1998; 394: 690-4.
42. Connolly AJ, Ishihara H, Kahn ML, et al. Role of the thrombin receptor in development and evidence for a second receptor. Nature 1996; 381: 516-9.
43. Ishihara H, Connolly AJ, Zeng D, et al. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 1997; 386: 502-6.
44. Nakanishi-Matsui M, Zheng YW, Sulciner DJ, et al. PAR3 is a cofactor for PAR4 activation by thrombin. Nature 2000; 404: 609-13.
45. Sambrano GR, Weiss EJ, Zheng YW, et al. Role of thrombin signalling in platelets in haemostasis and thrombosis. Nature 2001; 413: 74-8.
46. Coughlin SR. Protease-activated receptors in vascular biology. Thromb Haemost 2001; 86: 298-307.
47. Weiss EJ, Hamilton JR, Lease KE, Coughlin SR. Protection against thrombosis in mice lacking PAR3. Blood 2002; 100: 3240-4.
48. Kunapuli SP, Dorsam RT, Kim S, et al. Platelet purinergic receptors. Curr Opin Pharmacol 2003; 3: 175-80.
49. Cattaneo M, Gachet C. The platelet ADP receptors. Haematologica 2001; 86: 346-8.
50. Gurbel PA, Malinin AI, Callahan KP, et al. Effect of loading with clopidogrel at the time of coronary stenting on platelet aggregation and glycoprotein IIb/IIIa expression and platelet-leukocyte aggregate formation. Am J Cardiol 2002; 90: 312-5.
51. 1-deficient mice. Nat Med 1999; 5: 1199-202.
52. 1 receptor-null mice. J Clin Invest 1999; 104: 1731-7.
53. 12 regulates platelet adhesion/activation, thrombus stability in injured arteries. J Clin Invest 2003; 112: 398-406.
54. Gachet C. ADP receptors of platelets and their inhibition. Thromb Haemost 2001; 86: 222-32.
55. Hoff J. Methods of blood collection in the mouse. Lab Animal 2004; 29: 47-53.
56. Bi L, Lawler AM, Antonarakis SE, et al. Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nat Genet 1995; 10: 119-21.
57. Kung SH, Hagstrom JN, Cass D, et al. Human factor IX corrects the bleeding diathesis of mice with hemophilia B. Blood 1998; 91: 784-90.
58. Broze GJ, Jr., Yin ZF, Lasky N. A tail vein bleeding time model and delayed bleeding in hemophiliac mice. Thromb Haemost 2001; 85 (4): 747-8.
59. Schafer K, Konstantinides S, Riedel C, et al. Different mechanisms of increased luminal stenosis after arterial injury in mice deficient for urokinase- or tissue-type plasminogen activator. Circulation 2002; 106: 1847-52.
60. Falati S, Gross P, Merrill-Skoloff G, et al. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med 2002; 8: 1175-81.
61. Singletary KB, Kloster CA, Baker DG. Optimal age at fostering for derivation of Helicobacter hepaticus-free mice. Comp Med 2003; 53: 259-64.
62. Byrne MF, Kerrigan SW, Corcoran PA, et al. Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation. Gastroenterology 2003; 124: 1846-54.
63. Wakae T, Takatsuka H, Mori A, et al. Influence of Helicobacter pylori on platelets after bone marrow transplantation from unrelated donors. Bone Marrow Transplant 2003; 31: 493-6.
64. Lawler J, Sunday M, Thibert V, et al. Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J Clin Invest 1998; 101: 982-92.
65. 2 expression is associated with altered platelet responses to collagen. Blood 2004; 103: 3396-402.
66. 1. Blood 1998; 92: 2382-8.
67. Kunicki TJ. The influence of platelet collagen receptor polymorphisms in hemostasis and thrombotic disease. Arterioscler Thromb Vasc Biol 2002; 22: 14-20.